Novel PET Imaging Agent Targets Copper Atoms
|
By MedImaging International staff writers Posted on 21 Mar 2018 |
|
Image: 64CuCl2 PET/CT images reveal two positive small lymph nodes (A, C), whereas 18F-Choline PET/CT (B, D) is negative (Photo courtesy of Arnoldo Piccardo/ Galliera Hospital).
A novel positron emission tomography/computed tomography (PET/CT) imaging agent that traces copper accumulation in tumors can help detect prostate cancer (PC) recurrence, according to a new study.
Researchers at Galliera Hospital (Genoa, Italy), Humanitas Research Hospital (Milano, Italy), and other institutions conducted a study that prospectively evaluated 50 PC patients with relapse after surgery or external-beam radiation therapy (EBRT), as identified by rising prostate-specific antigen (PSA) levels. All patients underwent 64CuCl2 PET/CT, 18F-choline PET/CT, and multi-parametric magnetic resonance imaging (mpMRI) within a 15-day period in order to evaluate and compare the biodistribution, kinetics, and radiation dosimetry of 64CuCl2 in humans.
Experienced readers interpreted the images, and the detection rate of each imaging modality was then calculated. Histopathology, clinical or laboratory response, and multidisciplinary follow-up were used to confirm the site of disease. The results revealed that maximum 64CuCl2 uptake at PC sites relapse was observed one hour after tracer injection. 64CuCl2 PET/CT proved positive in 41 of 50 patients, with an overall detection rate of 82%; detection rates of 18F-choline PET/CT and mpMRI were 56% and 74%, respectively. The study was published in the March 2018 issue of The Journal of Nuclear Medicine.
“This study determined that the biodistribution of 64CuCl2 is more suitable than that of 18F-Choline for exploring the pelvis and prostatic bed,” said lead author Arnoldo Piccardo, MD, of Galliera Hospital. “Early detection of prostate cancer relapse may improve the clinical management of patients, for example implementing early salvage radiotherapy. Larger trials with this PET tracer are expected to further define its capabilities and role in the management of prostate cancer.”
Copper-64 is a positron-emitting isotope of copper, with applications for molecular radiotherapy and PET. The coordination chemistry of copper allows for its reaction with a wide variety of chelator systems that can be linked to antibodies, proteins, peptides, and other biologically relevant small molecules. The longer half-life of 64Cu delivers optimal bio-distribution of slower clearing agents, such as monoclonal antibodies, nanoparticles, and higher molecular weight polypeptides requiring longer imaging times.
Related Links:
Galliera Hospital
Humanitas Research Hospital
 Guided Devices.jpg)
Researchers at Galliera Hospital (Genoa, Italy), Humanitas Research Hospital (Milano, Italy), and other institutions conducted a study that prospectively evaluated 50 PC patients with relapse after surgery or external-beam radiation therapy (EBRT), as identified by rising prostate-specific antigen (PSA) levels. All patients underwent 64CuCl2 PET/CT, 18F-choline PET/CT, and multi-parametric magnetic resonance imaging (mpMRI) within a 15-day period in order to evaluate and compare the biodistribution, kinetics, and radiation dosimetry of 64CuCl2 in humans.
Experienced readers interpreted the images, and the detection rate of each imaging modality was then calculated. Histopathology, clinical or laboratory response, and multidisciplinary follow-up were used to confirm the site of disease. The results revealed that maximum 64CuCl2 uptake at PC sites relapse was observed one hour after tracer injection. 64CuCl2 PET/CT proved positive in 41 of 50 patients, with an overall detection rate of 82%; detection rates of 18F-choline PET/CT and mpMRI were 56% and 74%, respectively. The study was published in the March 2018 issue of The Journal of Nuclear Medicine.
“This study determined that the biodistribution of 64CuCl2 is more suitable than that of 18F-Choline for exploring the pelvis and prostatic bed,” said lead author Arnoldo Piccardo, MD, of Galliera Hospital. “Early detection of prostate cancer relapse may improve the clinical management of patients, for example implementing early salvage radiotherapy. Larger trials with this PET tracer are expected to further define its capabilities and role in the management of prostate cancer.”
Copper-64 is a positron-emitting isotope of copper, with applications for molecular radiotherapy and PET. The coordination chemistry of copper allows for its reaction with a wide variety of chelator systems that can be linked to antibodies, proteins, peptides, and other biologically relevant small molecules. The longer half-life of 64Cu delivers optimal bio-distribution of slower clearing agents, such as monoclonal antibodies, nanoparticles, and higher molecular weight polypeptides requiring longer imaging times.
Related Links:
Galliera Hospital
Humanitas Research Hospital
New
Ultrasound-Guided Biopsy & Visualization Tools
Endoscopic Ultrasound (EUS) Guided Devices
Diagnostic Ultrasound System
MS1700C
Multi-Use Ultrasound Table
Clinton
Computed Tomography System
Aquilion ONE / INSIGHT Edition
Latest General/Advanced Imaging News
- AI-Powered Imaging System Improves Lung Cancer Diagnosis
- AI Model Significantly Enhances Low-Dose CT Capabilities
- Ultra-Low Dose CT Aids Pneumonia Diagnosis in Immunocompromised Patients
- AI Reduces CT Lung Cancer Screening Workload by Almost 80%
- Cutting-Edge Technology Combines Light and Sound for Real-Time Stroke Monitoring
- AI System Detects Subtle Changes in Series of Medical Images Over Time
- New CT Scan Technique to Improve Prognosis and Treatments for Head and Neck Cancers
- World’s First Mobile Whole-Body CT Scanner to Provide Diagnostics at POC
- Comprehensive CT Scans Could Identify Atherosclerosis Among Lung Cancer Patients
- AI Improves Detection of Colorectal Cancer on Routine Abdominopelvic CT Scans
- Super-Resolution Technology Enhances Clinical Bone Imaging to Predict Osteoporotic Fracture Risk
- AI-Powered Abdomen Map Enables Early Cancer Detection
- Deep Learning Model Detects Lung Tumors on CT
- AI Predicts Cardiovascular Risk from CT Scans
- Deep Learning Based Algorithms Improve Tumor Detection in PET/CT Scans
- New Technology Provides Coronary Artery Calcification Scoring on Ungated Chest CT Scans
Channels
Radiography
view channel
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
Lung cancer continues to be the leading cause of cancer-related deaths worldwide. While advanced technologies like CT scanners play a crucial role in detecting lung cancer, more accessible and affordable... Read more
MRI
view channel
Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
Approximately 360,000 individuals in the UK suffer from focal epilepsy, a condition in which seizures spread from one part of the brain. Around a third of these patients experience persistent seizures... Read more
AI-Powered MRI Technology Improves Parkinson’s Diagnoses
Current research shows that the accuracy of diagnosing Parkinson’s disease typically ranges from 55% to 78% within the first five years of assessment. This is partly due to the similarities shared by Parkinson’s... Read more
Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
Artificial intelligence (AI) technologies are transforming the way medical images are analyzed, offering unprecedented capabilities in quantitatively extracting features that go beyond traditional visual... Read more
First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
Each year, approximately 800,000 people in the U.S. experience strokes, with marginalized and minoritized groups being disproportionately affected. Strokes vary in terms of size and location within the... Read moreUltrasound
view channel
Smart Ultrasound-Activated Immune Cells Destroy Cancer Cells for Extended Periods
Chimeric antigen receptor (CAR) T-cell therapy has emerged as a highly promising cancer treatment, especially for bloodborne cancers like leukemia. This highly personalized therapy involves extracting... Read more
Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more
High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
Each year, approximately one million prostate cancer biopsies are conducted across Europe, with similar numbers in the USA and around 100,000 in Canada. Most of these biopsies are performed using MRI images... Read more
World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
Ultrasound devices play a vital role in the medical field, routinely used to examine the body's internal tissues and structures. While advancements have steadily improved ultrasound image quality and processing... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read more
Imaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more